2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Evening Seminar

[ES28] Evening Seminar 28　New treatment for advanced / recurrent endometrial cancer～Focusing on Pembrolizumab + Lenvatinib combination therapy: KEYNOTE-775 study～

Fri. Feb 18, 2022 6:40 PM - 7:30 PM Room 8 (Sakura, 1F, Kyoto International Conference Center)

Chair：Keiichi Fujiwara（Department of Gynecologic Oncology, Saitama Medical University International Medical Center）

Sponsored by MSD K.K. / Eisai Co., Ltd.

[ES28-1] New treatment for advanced / recurrent endometrial cancer～Focusing on Pembrolizumab + Lenvatinib combination therapy: KEYNOTE-775 study～

○Kosei Hasegawa (Department of Gynecologic Oncology, Saitama Medical University International Medical Center)